Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 34 holding rows worth $180,276,000.

Accession
0001420506-19-001121
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 34 entries on the cover page, a total value of $180,276,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $180,276,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock128,000$17,571,000thousands by filing date
Bristol-Myers Squibb Company110122108COM304,900$15,461,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock888,152$13,473,000thousands by filing date
UNIQURE NVN90064101SHS328,978$12,949,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock132,937$10,602,000thousands by filing date
HANGER INC41043F208COMMON STOCK395,000$8,050,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK325,385$7,754,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW163,133$7,467,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock165,000$7,138,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM346,149$6,300,000thousands by filing date
AC IMMUNE SAH00263105SHS1,248,453$6,180,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM89,952$6,063,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,515,072$6,011,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK338,096$5,393,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK252,500$5,050,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A62,591$5,025,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM790,228$4,165,000thousands by filing date
R1 RCM INC749397105COM408,958$3,652,000thousands by filing date
HUMANA INC COM444859102Stock12,000$3,068,000thousands by filing date
AbbVie,Inc.00287Y109COM39,000$2,953,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM153,303$2,775,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM558,159$2,741,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock41,700$2,662,000thousands by filing date
ARQULE INC04269E107COM364,797$2,616,000thousands by filing date
ADMA BIOLOGICS INC000899104COM548,409$2,440,000thousands by filing date
TELIGENT INC NEW87960W104COM2,446,043$2,323,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM587,626$2,309,000thousands by filing date
PERSONALIS INC71535D106COMMON STOCK115,214$1,691,000thousands by filing date
Cigna Corporation125523100COM11,000$1,670,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM222,994$1,470,000thousands by filing date
REATA PHARMACEUTICALS INC75615P903CALL12,300$988,000thousands by filing datecall
UROVANT SCIENCESG9381B108COMMON STOCK102,657$972,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM2,366,707$924,000thousands by filing date
MILLENDO THERAPEUTICS INC60040X103COM52,051$370,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-001121this filing2019-11-14acceptance time not in the bulk data set